Severe Acute Respiratory Syndrome News and Research

Latest Severe Acute Respiratory Syndrome News and Research

Current hygiene guidelines appropriate for UK and SA variants of SARS-CoV-2, study finds

Current hygiene guidelines appropriate for UK and SA variants of SARS-CoV-2, study finds

Researchers provide ultrastructural details of SARS-CoV-2-infected respiratory epithelial cells

Researchers provide ultrastructural details of SARS-CoV-2-infected respiratory epithelial cells

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

Researchers explore an inhalable SARS-CoV-2 nanobody therapy

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

SARS-CoV-2 spike E484K mutation reduces antibody neutralization

Researchers work to develop dual antigen COVID-19 vaccine candidate

Researchers work to develop dual antigen COVID-19 vaccine candidate

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Could N protein-based COVID-19 vaccines hinder SARS-CoV-2's NK cell inhibition?

Tapeworm infection drug blocks SARS-CoV-2 damage in the lungs

Tapeworm infection drug blocks SARS-CoV-2 damage in the lungs

COVID19's cytokine storm ushers in a local complement storm in the lungs

COVID19's cytokine storm ushers in a local complement storm in the lungs

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Screening for SARS-CoV-2 non-structural protein 14 inhibitors

Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants

Commercial assays detect mRNA-1273 and BNT162b2 vaccine-induced SARS-CoV-2 antibodies in most vaccinated participants

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

The role and ancestry of the SARS-CoV-2 spike protein glycan shield

Lung microbiome predicts COVID-19 disease severity

Lung microbiome predicts COVID-19 disease severity

mRNA-based COVID-19 vaccination during pregnancy provides passive SARS-CoV-2 immunity to neonates 16 days after first dose

mRNA-based COVID-19 vaccination during pregnancy provides passive SARS-CoV-2 immunity to neonates 16 days after first dose

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

Researchers unveil new SARS-CoV-2 inhibitor that targets viral immune evasion

L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

L452R and Y453F SARS-CoV-2 mutations increase transmission and evade immunity

Pregnant women transmit SARS-CoV-2 and vaccine-induced antibodies to fetus

Pregnant women transmit SARS-CoV-2 and vaccine-induced antibodies to fetus

Previously approved drugs starting points for COVID-19 therapeutics

Previously approved drugs starting points for COVID-19 therapeutics

New polypeptide could provide universal protection against coronaviruses

New polypeptide could provide universal protection against coronaviruses

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers identify several novel SARS-CoV-2 inhibitors

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

Researchers discover a new monoclonal antibody that is effective against SARS-CoV-2 variants

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.